A Combination of UTMD-Mediated HIF-1<i>α</i> shRNA Transfection and TAE in the Treatment of Hepatic Cancer.
第一作者:
Yangying,Liao
第一单位:
Department of Ultrasound, Dongguan People's Hospital Affiliated to Southern Medical University, No. 3 New Valley Chung Wan Road South, Wanjiang District, Dongguan, 523059, Guangdong, China.
作者:
医学主题词
动物(Animals);癌, 肝细胞(Carcinoma, Hepatocellular);栓塞, 治疗性(Embolization, Therapeutic);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);缺氧诱导因子1, α亚基(Hypoxia-Inducible Factor 1, alpha Subunit);肝肿瘤, 实验性(Liver Neoplasms, Experimental);男(雄)性(Male);肿瘤蛋白质类(Neoplasm Proteins);RNA, 小分子干扰(RNA, Small Interfering);大鼠(Rats);大鼠, Wistar(Rats, Wistar);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1155/2019/1937460
PMID
30911540
发布时间
2020-02-25
- 浏览5
BioMed research international
2019年2019卷
1937460页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



